Creative Details

Quality Score: 6/10

The advertisement promotes the availability of Zepbound clinical trial data and encourages viewers to discover the information and see the trial results.

Creative Information

CID:	9fbdb92b-ff26-44da-a53e-6b88a225b865
CRID:	29_650979856
Domain:	pathtosuccess.global
Seat:	Xandr
Size:	320x50
Bid:	$0.49
Timestamp:	11/4/2025, 4:14:28 PM
Declared IAB Categories:

Analysis

5 succeeded(100% complete)

Task	Status	Last Updated	Duration
ad_analysis	success	11/26/2025, 10:37:05 PM	5.98s
adomain_analysis	success	11/26/2025, 10:37:04 PM	2.45s
adomain_capture	success	11/26/2025, 10:37:01 PM	0.16s
ad_render	success	11/26/2025, 10:36:59 PM	9.18s
brand_mapping	success	11/26/2025, 10:37:02 PM	1.22s

Analysis Results

Ad Format: banner

Brands:

Size:

320x50

Data Transferred:

1456.31 KB

Render Time:

8.06 Seconds

Creative Inferred IAB Categories:

Health & Fitness (IAB7)
Science (IAB15)

Creative Inferred IAB Ad Products:

Health and Medical Services (1378)
Clinical Research (1382)

Total Ad Size:

1456.35 KB

Requests Made:

URL	Size (KB)
https://cdn.doubleverify.com/dvbm.js	529.96
https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js	222.95
https://adsdkprod.azureedge.net/viewability/versions/v5.8.22/banner.js	152.75
https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js	116.69
https://ad.doubleclick.net/ddm/adj/N6275.5199567ADDAPTIVEINTELLIGEN/B33725440.425093500;dc_ver=106.314;sz=320x50;u_sd=1;gdpr=0;nel=1;dc_adk=2027040026;ord=lghpsl;click=https%3A%2F%2Fnym2-ib.adnxs.com%2Fclick2%3Fe%3DwqT_3QKiAfCBogAAAAMAxBkFAQjmkZnJBhCrrfG2pY7Xy0sY_p6Z5PjQ4IhTIJjAzQoo7T8wuwY4AkCQ1LS2Aki1-F1QAFoDVVNEYgNVU0RowAJwMnjf-WiAAafqBYgBAZABApgBBaABAqkB64uEtpxL5T-xAWFvYkhO5uI_uQEAAACAwvUkQMEBYQ0UAMkVKDjYAZynA-ABAPAB_wH4AQA.%2Fs%3Dd069b2101b357d27ba3ab6b7d81dd4028234f364%2Fbcr%3DAAAAAAAA8D8%3D%2Fcnd%3D%25219hGNFwjmufUeEJDUtLYCGLX4XSAAKAAxAAAAAAAADEA6CU5ZTTI6NjQ3NkDiSkkAAAAAAADwP1EAAAAAAAAAAFkAAAAAAAAAAGEAAAAAAAAAAGkAAAAAAAAAAHEAAAAAAAAAAHgAiQEAAAAAAADwPw..%2Fcca%3DODI3I05ZTTI6NjQ3Ng%3D%3D%2Fbn%3D95527%2Fclickenc%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=xoGkTZb'Jb;gcsr=m;stc=1;chaa=1;sttr=49;prcl=s	102.36
https://s0.2mdn.net/sadbundle/16063949461231305746/TIR_HCP_320x50_V2_corrected/TIR_HCP_320x50_V2/edge.5.0.1.min.js	101.46
https://www.googletagservices.com/dcm/impl_v106.js	68.78
https://ep1.adtrafficquality.google/bg/EhG3m84SjVzKh4BiJhjb_O-dt4UrFNNFgVckzA1wIYM.js	53.49
https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js	42.74
https://www.googletagservices.com/dcm/dcmads.js	16.68

Advertiser Domain

Ad Preview

Raw Ad Markup

<script src="https://nym2-ib.adnxs.com/ab?an_audit=0&referrer=https%3A%2F%2Fwww.androidpolice.com%2Fandroid-auto-android-evolved%2F&e=wqT_3QKXEvBMFwkAAAMA1gAFAQjmkZnJBhCrrfG2pY7Xy0sY_p6Z5PjQ4IhTKjYJ64uEtpxL5T8RYW9iSE7m4j8ZAAAAgML1JEAhYW9iSE7m4j8p64sJJNAxAAAAoHA9FEAwmMDNCjjtP0C7BkgCUJDUtLYCWLX4XWAAaN_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_ICEQoGQURWX0lEEgeNSRzyAhIKBkNQRwEUBAgyjTQBFQgFQ1ABFAAJlTMQ8gINCggBPhhGUkVREgEyBRA0UkVNX1VTRVISATDyAgwJIBRDT0RFEgAFDwFZEQ8QCwoHQ1AVDhARCgVJTwFhAAiRvgDyASIESU8VIjgTCg9DVVNUT01fTU9ERUwBLBQA8gIaChYyFgAcTEVBRl9OQU0FcggeCho2HQAIQVNUAT4QSUZJRUQBPhwVCghTUExJVAFNGdr0FwGAAwCIAwGQAwCYAxSgAwGqAwJIAMAD2ATIAwDYA9nxGuADAOgDAfgDA4AEAJIECS9vcGVucnRiMpgEAKIEDDIwNy4zNS44LjI1MqgEo8IVsgQOCAAQABgAIAAwADgAQgC4BADABADIBADSBA04MjcjTllNMjo2NDc22gQCCAHgBADwBJDUtLYCiAUBmAUAoAX___________8BqgUkMTVhNWVlYTEtOTkwZi00MWY1LTkyMmYtY2UwMjlhNDI5NzU3wAUAyQUAAAAAAADwP9IFCQkAAAAAAAAAANgFAeAFAfAFm9uBAfoFBAgAEACQBgCYBgC4BgDBBgAAAAAAAPA_0Ab_AdoGFgoQAAAAAAAAAAAAAAAAAAAABcVg4AYB8gYCCACABwGIBwCgBwHIB6fqBdIHDxVlBBAAAesM2gcGCAUL9LsB4AcA6gcCCADwB4v2CIoI_wIK-gIAAAGavYzCcEuXXHJW3Far2JLP_vJhlLRqgPtAi_W40_qusf35F0taeWHnMuAAIPpPTmEfW-c3MpvGvPzZG0eHrQo9G_TfNDCUwwY6hy3OA4wZ9L7rvvrjBlU3lrx2XNT1rQ9SHYcvoEE-5_GhKRzyUJHVLClsj7kNQhj4WXINa6W8kpstQQkZUB1BonCvJrXMARz87cdcIKGyueU6Ulix8CO0Y1-aUOeYlJxc0pZHCq2KRlJWEhT9Mb16Qkt-fXh4rPL_-BpgA0luCSJj5KjnSqI2UBQrSwXIWOaDv2TjFrd0Aq66MdISEnbCULilM46J0YtpuKHInhDxZocxnQ4YWVm_YeiSPptf0Q-iIMq6uM2sSfeHtVylMQTUQs0K3RpcF54Ev04BNMC24ZAfxhX-In9sDHwDI_3gebs0046XhSwQLFrra2KHSyC3OQJ2DMF02hVJ3GkRRGjxNOOFuoJYWFbD44ogiR-Za5VLcG1igTkUkoyyGnNAgGcQAZUIAACAP5gIAsAInKcD0ggOCIGChIiQoMCAARAAGADaCAQIACAA4AgA6AgA&s=621fa8fa9243c7acb0ee23a7f96a2abc0aa78715&pp=0.590614"></script>